About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Comparison Between Treatments of Oligohydramnios | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 2NCT07135037

Comparison Between Treatments of Oligohydramnios

Based on previous studies, Both sildenafil and L-arginine helped to improve idiopathic oligohydramnios. In this study, Level of improvment of oligohydramnios will be compared. As well as, NICU admiss...

Lead sponsor: Kafrelsheikh University•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ibtesam T Gadalla, MBBch

CONTACT

1025193157 bassmagadalla@gmail.com

Mostafa F El-lakany, PHD

CONTACT

10116083210 Mfe_2014@yahoo.com

Sponsors

Lead Sponsor

Kafrelsheikh University

Age

18 - 35 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Pregnant women with gestational age between 26-37 weeks
•Pregnant women whose age is \< 35 years
•Woman with other indication for elective caesarean section.
•Women carrying a single fetus with no major anomalies.
•Initial amniotic fluid index \<8cm determined by reliable pelivabdominal ultrasound.

Exclusion Criteria

•Women complaining of other obstetric disorder such as, PPROM, preeclampsia, or diabetes.
•Women with chronic illness such as, chronic hypertension, autoimmune disease or kidney disease.
•Women who received other treatments for oligohydramnios in current pregnancy.
•Women who smoke.
•Fetuses with major congenital anomaly.

Related studies

PPROM Registry (Preterm Premature Rupture of Membranes)

NCT02997345 · Fetal Membranes, Premature Rupture, Preterm Premature Rupture of the Membranes, and more

"Fetal gRowth AbnorMality dEtection Trial"

NCT05043753 · Small for Gestational Age Infant, Large for Gestational Age Infant, and more

Active Not Recruiting

Dilapan-S®: A Multicenter US E-registry

NCT04451109 · Post Term Pregnancy, Premature Rupture of Membrane, and more

Effect of Intermittent Pneumatic Compression Device of Lower Limbs in Oligohydramnios

NCT05474326 · Oligohydramnios, Amniotic Fluid; Disorder

The Role of Zamzam Water in Idiopathic Oligohydramnios

NCT04684680 · Oligohydramnios

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 21, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment40

Start dateSep 2024

Last updatedAug 21, 2025

Condition

Oligohydramnios

Locations shown

Kafrelsheikh University Hospital

Kafr ash Shaykh, Kafrelsheikh

Kafrelsheokh university hospital

Kafr ash Shaykh, Kafrelsheikh

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 21, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions